...
首页> 外文期刊>European journal of clinical microbiology and infectious diseases: Official publication of the European Society of Clinical Microbiology >Viruses and atypical bacteria in the respiratory tract of immunocompromised and immunocompetent patients with airway infection
【24h】

Viruses and atypical bacteria in the respiratory tract of immunocompromised and immunocompetent patients with airway infection

机译:免疫血肿和免疫活性患者的呼吸道病毒和非典型细菌患者气道感染

获取原文
获取原文并翻译 | 示例
           

摘要

Respiratory tract infections (RTI) can take a serious course under immunosuppression. Data on the impact of the underlying pathogens are still controversial. Samples from the upper (n = 322) and lower RT (n = 169) were collected from 136 children and 355 adults; 225 among them have been immunocompromised patients. Exclusion criteria were presence of relevant cultivable microorganisms, C-reactive protein > 20 mg/dl, or procalcitonin > 2.0 ng/ml. Samples were tested by PCR for the presence of herpesviruses (HSV-1/-2; VZV; CMV; HHV6; EBV), adenoviruses, bocaviruses, entero-/rhinoviruses (HRV), parechoviruses, coronaviruses, influenza viruses (IV), parainfluenza viruses as well as for pneumoviruses (HMPV and RSV), and atypical bacteria (Mycoplasma pneumoniae, M.p.; Chlamydia pneumoniae, C.p.). Viral/bacterial genome equivalents were detected in more than two-thirds of specimens. Under immunosuppression, herpesviruses (EBV 30.9%/14.6%, p < 0.001; CMV 19.6%/7.9%, p < 0.001; HSV-1: 14.2%/7.1%, p = 0.012) were frequently observed, mainly through their reactivation in adults. Immunocompromised adults tended to present a higher RSV prevalence (6.4%/2.4%, p = 0.078). Immunocompetent patients were more frequently tested positive for IV (15.0%/5.8%, p = 0.001) and M.p. (6.4%/0.4%, p < 0.001), probably biased due to the influenza pandemic of 2009 and an M.p. epidemic in 2011. About 41.8% of samples were positive for a single pathogen, and among them EBV (19.9%) was most prevalent followed by HRV (18.2%) and IV (16.6%). HSV-2 and C.p. were not found. Marked seasonal effects were observed for HRV, IV, and RSV. Differences in pathogen prevalence were demonstrated between immunocompetent and immunocompromised patients. The exact contribution of some herpesviruses to the development of RTI remains unclear.
机译:呼吸道感染(RTI)可以在免疫抑制下进行严重的课程。关于潜在病原体的影响的数据仍存在争议。从136名儿童和355名成人收集来自上部(n = 322)和低温(n = 169)的样品; 225其中225岁的患者都是免疫疗效。排除标准是相关可栽培微生物,C-反应蛋白> 20mg / dL,或ProCalcitonin> 2.0ng / ml的存在。通过PCR测试样品以存在疱疹病毒(HSV-1 / -2; VZV; CMV; HHV6; EBV),腺病毒,双鲕瓣,肠道病毒(HRV),鉴别病毒,冠状病毒,流感病毒(IV),Parainfluenza病毒以及肺病毒(HMPV和RSV)和非典型细菌(支原体肺炎,MP; Chlamydia Pneumoniae,CP)。在超过三分之二的标本中检测到病毒/细菌基因组等同物。在免疫抑制下,疱疹病毒(EBV 30.9%/ 14.6%,P <0.001; CMV 19.6%/ 7.9%,P <0.001; HSV-1:14.2%/ 7.1%,P = 0.012)主要是通过其再激活成年人。免疫染色的成年人倾向于呈现较高的RSV患病率(6.4%/ 2.4%,P = 0.078)。免疫活性患者对IV的阳性更频繁(15.0%/ 5.8%,P = 0.001)和M.P。 (6.4%/ 0.4%,P <0.001),可能由于2009年的流感大流行病和M.P. 2011年的流行病。约41.8%的样品对单个病原体阳性,其中EBV(19.9%)最普遍,其次是HRV(18.2%)和IV(16.6%)。 HSV-2和C.P.找不到。为HRV,IV和RSV观察到明显的季节性效果。在免疫活性剂和免疫功能性患者之间证明了病原体患病率的差异。一些疱疹病毒对RTI发展的确切贡献仍然尚不清楚。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号